LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships AVEO Oncology forming partnerships with companies like Nikangtx and Annexus Health presents potential collaboration opportunities to leverage a broader network for sales and distribution channels.

Acquisition by LG Chem LG Chem's acquisition of AVEO Oncology provides access to a strong financial backing and resources, enabling potential expansion of product offerings and market reach, creating new sales avenues.

Honored Workplace Being recognized as one of the top places to work indicates a positive company culture that can appeal to top talent in the industry, leading to a motivated sales team and increased productivity.

New Chief Medical Officer Hiring a Chief Medical Officer showcases AVEO's commitment to bolstering its leadership team, bringing in new expertise that can drive innovative strategies to enhance product sales and market positioning.

Innovative Third-Line Therapy AVEO Oncology's launch of a third-line therapy demonstrates a focus on innovation and addressing unmet medical needs, creating opportunities for new revenue streams and differentiated offerings in the market.

Similar companies to AVEO Oncology

AVEO Oncology Tech Stack

AVEO Oncology uses 8 technology products and services including Google Analytics, WordPress, ADP, and more. Explore AVEO Oncology's tech stack below.

  • Google Analytics
    Analytics
  • WordPress
    Content Management System
  • ADP
    Human Resource Management System
  • CDW
    IT
  • Exhibit
    Javascript Graphics
  • Acquia Cloud Platform
    Platform As A Service
  • Akamai Web Application Protector
    Security
  • Drupal Multisite
    Web Hosting

Media & News

AVEO Oncology's Email Address Formats

AVEO Oncology uses at least 1 format(s):
AVEO Oncology Email FormatsExamplePercentage
FLast@aveooncology.comJDoe@aveooncology.com
76%
Last@aveooncology.comDoe@aveooncology.com
18%
First.Last@aveooncology.comJohn.Doe@aveooncology.com
5%
FL@aveooncology.comJD@aveooncology.com
1%

Frequently Asked Questions

Where is AVEO Oncology's headquarters located?

Minus sign iconPlus sign icon
AVEO Oncology's main headquarters is located at 30 Winter St 3rd Floor Boston, Massachusetts 02108 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is AVEO Oncology's phone number?

Minus sign iconPlus sign icon
You can contact AVEO Oncology's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AVEO Oncology's official website and social media links?

Minus sign iconPlus sign icon
AVEO Oncology's official website is aveooncology.com and has social profiles on LinkedIn.

How much revenue does AVEO Oncology generate?

Minus sign iconPlus sign icon
As of October 2024, AVEO Oncology's annual revenue reached $35M.

What is AVEO Oncology's SIC code NAICS code?

Minus sign iconPlus sign icon
AVEO Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AVEO Oncology have currently?

Minus sign iconPlus sign icon
As of October 2024, AVEO Oncology has approximately 197 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: M. B.Chief Financial Officer: J. J.Vice President Of Clinical Operations: N. R.. Explore AVEO Oncology's employee directory with LeadIQ.

What industry does AVEO Oncology belong to?

Minus sign iconPlus sign icon
AVEO Oncology operates in the Biotechnology Research industry.

What technology does AVEO Oncology use?

Minus sign iconPlus sign icon
AVEO Oncology's tech stack includes Google AnalyticsWordPressADPCDWExhibitAcquia Cloud PlatformAkamai Web Application ProtectorDrupal Multisite.

What is AVEO Oncology's email format?

Minus sign iconPlus sign icon
AVEO Oncology's email format typically follows the pattern of . Find more AVEO Oncology email formats with LeadIQ.

How much funding has AVEO Oncology raised to date?

Minus sign iconPlus sign icon
As of October 2024, AVEO Oncology has raised $55M in funding. The last funding round occurred on Mar 22, 2021 for $55M.

When was AVEO Oncology founded?

Minus sign iconPlus sign icon
AVEO Oncology was founded in 2001.
AVEO Oncology

AVEO Oncology

Biotechnology ResearchMassachusetts, United States51-200 Employees

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

Section iconCompany Overview

Headquarters
30 Winter St 3rd Floor Boston, Massachusetts 02108 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
51-200

Section iconFunding & Financials

  • $55M

    AVEO Oncology has raised a total of $55M of funding over 16 rounds. Their latest funding round was raised on Mar 22, 2021 in the amount of $55M.

  • $10M$50M

    AVEO Oncology's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $55M

    AVEO Oncology has raised a total of $55M of funding over 16 rounds. Their latest funding round was raised on Mar 22, 2021 in the amount of $55M.

  • $10M$50M

    AVEO Oncology's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.